To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
General Atlantic-backed Rubicon buys Impopharma
Rubicon Research Private Limited, a a portfolio company of General Atlantic, has acquired Concord, Ontario-based Impopharma, a development and testing facility specializing in pulmonary and nasal drug products.
